Background illustration for clinical trials search

Paid Clinical Trials Plainfield

Discover 2,367 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

for
Ventricular Arrythmia, Ventricular Fibrillation,
Location: Glenview IL, Rochester MN, Lexington KY, Jonesboro AR,
Sponsor: AtaCor Medical, Inc.

Sex: All

Age: 18+

Code: NCT07324031

Recruiting

ICU CONNECT: Study Comparing EMG in Healthy Volunteers and ICU Patients.

for
ICU Acquired Weakness
Location: Evanston IL
Sponsor: Endeavor Health

Sex: All

Age: 18 - 70+

Code: NCT07699562

Recruiting

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

for
Agitation, Alzheimer's Type Dementia
Location: Chicago IL, Beachwood OH, Amherst NY, East Syracuse NY,
Sponsor: Suven Life Sciences Limited

Sex: All

Age: 50 - 70+

Code: NCT05397639

Phase3, Recruiting

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

for
Primary Membranous Nephropathy
Location: Chicago IL, Iowa City IA, Saint Clair Shores MI,
Sponsor: Cerium Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05696613

Phase3, Recruiting

Study of COYA 302 for the Treatment of ALS

for
Amyotrophic Lateral Sclerosis (ALS)
Location: Chicago IL, St Louis MO, Ann Arbor MI, London,
Sponsor: Coya Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07161999

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Chicago IL, Iowa City IA, Franklin TN, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT07109219

Phase1, Phase2, Recruiting

Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Chicago IL
Sponsor: Reem Karmali

Sex: All

Age: 18+

Code: NCT06723457

Phase2, Recruiting

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

for
Type 2 Diabetes, Cortisol Excess
Location: Chicago IL, Cincinnati OH, Edgewood KY, Troy MI,
Sponsor: Sparrow Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07296484

Phase2, Recruiting

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

for
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms,
Location: Chicago IL, Cincinnati OH, Memphis TN, Norcross GA,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT07484217

Phase3, Recruiting

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: Chicago IL, Cincinnati OH, Bryant AR, Atlanta GA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07573176

Phase3, Recruiting

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

for
Major Depressive Disorder
Location: Chicago IL, Saint Charles MO, Cincinnati OH,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06223880

Recruiting

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Metastatic Non-small Cell Lung Cancer
Location: Chicago IL, Evanston IL, Maumee OH, Detroit MI,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06417814

Phase3, Recruiting

Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma

for
Metastatic NUT Carcinoma, Unresectable NUT Carcinoma
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07050186

Phase2, Recruiting

Lysosomal Acid Lipase (LAL) Deficiency Registry

for
Lysosomal Acid Lipase Deficiency,
Location: Chicago IL, Detroit MI, Minneapolis MN, London,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 0+

Code: NCT01633489

Recruiting

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

for
Duchenne Muscular Dystrophy (DMD), Cardiomyopathy,
Location: Chicago IL, Indianapolis IN, Columbus OH, Nashville TN,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 0+

Code: NCT07674758

Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for
Non-Small Cell Lung Cancer
Location: Chicago IL, Evanston IL, Indianapolis IN, St Louis MO,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT06767514

Phase3, Recruiting
Featured

A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants

for
Healthy Volunteers
Location: Grayslake IL
Sponsor: AbbVie

Sex: All

Age: 18 - 55

Code: NCT07673120

Phase1, Recruiting

Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males

for
Inguinal Hernia Unilateral, Inguinal Hernia Bilateral,
Location: Chicago IL
Sponsor: Northwestern University

Sex: Male

Age: 50+

Code: NCT07604272

Phase1, Recruiting

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

for
Lung Non-Small Cell Carcinoma
Location: Ottawa IL, Peru IL, Princeton IL, Mukwonago WI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07388524

Phase3, Recruiting

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

for
Cystic Fibrosis
Location: Chicago IL, Iowa City IA, Detroit MI, Louisville KY,
Sponsor: Aridis Pharmaceuticals, Inc.

Sex: All

Age: 18 - 49

Code: NCT03669614

Phase1, Phase2, Recruiting